Interleukin-10 suppresses the development of collagen type II-induced arthritis and ameliorates sustained arthritis in rats

Scandinavian Journal of Immunology

Volumn 44, Issue 6, 1996, Pages 607-614

  Persson, S ^a   Mikulowska, A ^a   Narula, S ^b   O'Garra, A ^b   Holmdahl, R ^a  

^a LUND UNIVERSITY   (Sweden)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; COLLAGEN TYPE 2; RECOMBINANT INTERLEUKIN 10;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; ARTICLE; CONTROLLED STUDY; FEMALE; IMMUNIZATION; IMMUNOTHERAPY; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029796835     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1996.d01-355.x     Document Type: Article

References (50)

1. Holmdahl R, Andersson M, Goldschmidt TJ, Gustafsson K, Jansson L, Mo JA. Type II collagen autoimmunity in animals and provocations leading to arthritis. Immunol Rev 1990; 118: 193-232.
2. Trentham DE. Collagen arthritis as a relevant model for rheumatoid arthritis. Evidence pro and con. Arthritis Rheum 1982; 25:911-16.
3. Goldschmidt TJ, Holmdahl R. Anti-T cell receptor antibody treatment of rats with established autologous collagen-induced arthritis. Suppression of arthritis without reduction of anti-type II collagen autoantibody levels. Eur J Immunol 1991;21:1327-30.
4. Goldschmidt TJ, Holmdahl R. Therapeutic effects of monoclonal antibodies to alpha beta TCR but not to CD4 on collagen-induced arthritis in the rat. Cell Immunol 1994;154:240-8.
5. Griffiths M. Immunogenetics of collagen-induced arthritis in rats. Intern Rev Immunol 1988;4:1-15.
6. Holmdahl R, Vingsbo C, Hedrich H et al. Homologous collagen-induced arthritis in rats and mice are associated with structurally different major histocompatibility complex DQ-like molecules. Eur J Immunol 1992;22:419-24.
7. Fiorentino DF, Zlotnik A, Vieira P et al. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th 1 cells. J. Immunol 1991;146:3444-51.
8. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991;147:3815-22.
9. Bogdan C, Vodovotz Y, Nathan C. Macrophage deactivation by interleukin 10. J Exp Med 1991;174:1549-55.
10. Go NF, Castle BE, Barett R et al. Interleukin 10, a novel B cell stimulatory factor: Unresponsiveness of X-chromosome-linked immunodeficiency B cells. J Exp Med 1990;172:1625-31.
11. Chen WF, Zlotnik A. IL-10: a novel cytotoxic T cell differentiation factor. J Immunol 1991;147:528-34.
12. Thompson-Snipes L, Dhar V, Bond MW, Mosmann TR, Moore KW, Rennick DM. Interleukin 10: a novel stimulatory factor for mast cells and their progenitors. J Exp Med 1991;173:507-10.
13. MacNeil IA, Suda T, Moore KW, Mosmann TR, Zlotnik A, IL-10, a novel growth cofactor for mature and immature T cells. J Immunol 1990;145:4167-73.
14. Howard M, O'Garra A. Biological properties of interleukin 10. Immunology Today 1992;13:198-200.
15. Mosmann TR. Properties and functions of interleukin-10. Adv Immunol 1994;56:1-26.
16. O'Garra A, Stapleton G, Dhar V et al. Production of cytokines by mouse B cells: B lymphomas and normal B cells produce interleukin 10. Int Immunol 1990;2:821-32.
17. de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991;174:1209-20.
18. Cassatella MA, Meda L, Bonora S, Ceska M, Constantin G. Interleukin 10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes. Evidence for an autocrine role of tumor necrosis factor and IL-1 beta in mediating the production of IL-8 triggered by lipopolysaccharide. J Exp Med 1993;178:2207-11.
19. Kasama T, Stricter RM, Lukacs NW, Lincoln PM, Burdick MD, Kunkel SL. Interleukin-10 expression and chemokine regulation during the evolution of murine type II collagen-induced arthritis. J Clin Invest 1995;95:2868-76.
20. Murphy EE, Terres G, Macatonia SE et al. B7 and interleukin 12 cooperate for proliferation and interferon g production by mouse T helper clones that are unresponsive to B7 costimulation. J Exp Med 1994;180:223-31.
21. Rott O, Fleischer B, Cash E. Interleukin-10 prevents experimental allergic encephalomyelitis. Eur J Immunol 1994;24: 1434-40.
22. Hart PH, Ahern MJ, Smith MD, Finlay Jones JJ. Comparison of the suppressive effects of interleukin-10 and interleukin-4 on synovial fluid macrophages and blood monocytes from patients with inflammatory arthritis. Immunology 1995;84:536-42.
23. Gerard C, Bruyns C, Marchant A et al. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J Exp Med 1993;177:547-50.
24. Howard M, Muchamuel T, Andrade S, Menon S. Interleukin 10 protects mice from lethal endotoxemia. J Exp Med 1993;177: 1205-8.
25. Standiford TJ, Strieter RM, Lukacs NW, Kunkel SL. Neutralization of IL-10 increases lethality in endotoxemia. Cooperative effects of macrophage inflammatory protein-2 and tumor necrosis factor. J Immunol 1995;155:2222-9.
26. Marchant A, Bruyns C, Vandenabeele P et al. Interleukin-10 controls interferon-gamma and tumor necrosis factor production during experimental endotoxemia. Eur J Immunol 1994;24:1167-71.
27. Ishida H, Muchamuel T, Sakaguchi S, Andrade S, Menon S, Howard M. Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice. J Exp Med 1994;179:305-10.
28. Kühn R, Löhler J, Rennick D, Rajewsky K, Müller W. Interleukin-10 deficient mice develop chronic enterocolitis. Cell 1993; 75:263-74.
29. Katsikis PD, Chu CQ, Brennan FM, Maini RN, Feldmann M. Immunoregulatory role of interleukin 10 in rheumatoid arthritis. J Exp Med 1994;179:1517-27.
30. Walmsley M, Katsikis PD, Abney E et al. Interleukin-10 inhibition of the progression of established collagen-induced arthritis. Arthritis Rheum 1996;39:495-503.
31. Smith BD, Martin GR, Dorfman A, Swarm R. Nature of the collagen synthesized by a transplanted chondrosarcoma. Arch Biochem Biophys 1975;166:181-6.
32. Miller ES. Structural studies on cartilage employing limited cleavage and solubilization with pepsin. Biochemistry 1972;11: 4901-9.
33. Vingsbo C, Larsson P, Andersson M, Holmdahl R. Association of pepsin with type II collagen (CII) breaks control of CII autoimmunity and triggers development of arthritis in rats. Scand J Immunol 1993;37:337-42.
34. Persson S, Nyberg F, Holmdahl R, Post C. Decreased neuropeptide-converting enzyme activities in cerebrospinal fluid during acute but not chronic phases of arthritis in rats. Brain Research 1992; 581:273-82.
35. Moore KW, Vieira P, Fiorentino DF, Trounstine ML, Khan TA, Mosmann TR. Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Bar virus gene BCRFI. Science 1990;248: 1230-4.
36. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 1976;72:248-54.
37. Fiorentino DF, Bond MW, Mosmann TR. Two types of mouse helper T cells. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 1989;170:2081-95.
38. Li L, Elliott JF, Mosmann TR. IL-10 inhibits cytokine production, vascular leakage, and swelling during T helper 1 cell-induced delayed type hypersensitivity. J Immunol 1994;153:3967-78.
39. Holmdahl R, Klareskog L, Andersson M, Hansen C. High anti-body response to autologous type II collagen is restricted to H-2q. Immunogenetics 1986;24:84-9.
40. Larsson P, Kleinau S, Holmdahl R, Klareskog L. Homologous type II collagen-induced arthritis in rats. Characterization of the disease and demonstration of clinically distinct forms of arthritis in two strains of rats after immunization with the same collagen preparation. Arthritis Rheum 1990;33:693-701.
41. Pearson CM, Wood FD. Studies of polyarthritis and other lesions induced in rats by injection of mycobacterial adjuvant. I. General clinical and pathologic characteristics and some modifying factors. Arthritis Rheum 1959;2:440-59.
42. Chang YH, Pearson CM, Abe C. Adjuvant polyarthritis. IV. Induction by a synthetic adjuvant: Immunologic, histopathologic, and other studies. Arthritis Rheum 1980;23:62-71.
43. Vingsho C, Jonsson R, Holmdahl R. Avridine-induced arthritis in rats: a T cell-dependent chronic disease influenced both by MHC genes and by non-MHC genes. Clin Exp Immunol 1995; 99:359-63.
44. Griffiths MM, Cannon GW, Leonard PA, Reese VR. Induction of autoimmune arthritis in rats by immunization with homologous rat type II collagen is restricted to the RT1avl haplotype. Arthritis Rheum 1993;36:254-8.
45. Holmdahl R, Goldschmidt TJ, Kleinau S, Kvick C, Jonsson R. Arthritis induced in rats with adjuvant oil is a genetically restricted, alpha beta T-cell dependent autoimmune disease. Immunology 1992;76:197-202.
46. Holmdahl R, Vingsbo C, Malmström V, Jansson L, Holmdahl M. Chronicity of arthritis induced with homologous type II collagen (CII) in rats is dependent on anti-CII B-cell activation. J Autoimmunity 1994;7:739-52.
47. Itoh K, Hirohata S. The role of 1L-10 in human B cell activation, proliferation, and differentiation. J Immunol 1995;154:4341-50.
48. Levy Y, Brouet JC. Interleukin-10 prevents spontaneous death of germinal center B cells by induction of the bcl-2 protein. J Clin Invest 1994;93:424-8.
49. Nakajima H, Takamori H, Hiyama Y, Tsukada W. The effect of treatment with interferon-gamma on type II collagen-induced arthritis. Clin Exp Immunol 1990;81:441-5.
50. Mauritz NJ, Holmdahl R, Jonsson R, Van Der Meide P, Scheynius A, Klareskog L. Treatment with interferon gamma triggers onset of collagen arthritis in mice. Arthritis Rheum 1988; 31:1297-304.